Impotency drug cures Raynaud’s fingertip ulcers Vaccinations not linked to rheumatoid arthritis Colchicine safe for patients with comorbidities Arthritis biologics may cut Alzheimer’s risk Lowering urate cuts cardiovascular deaths Hyperuricemia deserves more aggressive treatment, researcher says Early treatment improves outcomes in rheumatoid arthritis Methotrexate-prednisone combo achieves remission in nearly two-thirds of patients Rheumatoid arthritis biologics may provoke shingles outbreaks Researchers advise clinicians to be vigilant when prescribing anti-TNF therapy Osteoporosis: There’s an app for that New Canadian guidelines offer a choice of risk assessment tools Uloric: first new option for gout in more than 40 years Takeda Canada will soon be introducing Uloric (febuxostat 80 mg) tablets, the first new drug to be marketed for gout in more than four decades. Men and Women's Health 2010: Osteoporosis New developments in therapy, vitamin D requirements, bisphosphonate safety and risk assessment. First Previous 17 18 19 20 Next Last
